Project Grant DP2DA063123
Award Date
6/15/25
Completion Date
5/31/29
Dollars Obligated
$2.3M
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
This Project Grant award of $1,377,306 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a multi-jurisdictional study to transform the evidence base on the prevalence of opioid use disorder (OUD) and the impact of opioid agonist treatment (OAT) as a strategy to prevent opioid-related harms. The study will leverage data linkages in the U.S. (Rhode Island, Wisconsin, Colorado, and Massachusetts), Australia (New South...
This $2,542,500 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support the development of novel econometric research methods to integrate real-world evidence (RWE) data into the analysis of inconclusive randomized controlled trials (RCTs) for opioid use disorder (OUD) treatments. The project aims to create a unified framework for using RWE to supplement RCT findings, particularly for vulnerable...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $683,583 to New York University (NYU) to conduct a simulation modeling study on the potential impacts of changes to methadone treatment delivery in New York State. The study aims to use an agent-based modeling approach to estimate the effects of four policy scenarios on methadone initiation, 6-month retention, fatal and non-fatal opioid...
This federal Project Grant award of $459,045, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is for a study titled "The Cascade of Care for Patients with Opioid Use Disorder Identified Through a Large Public Health System." The study aims to modify the existing Opioid Use Disorder (OUD) Cascade of Care model to better reflect the changing landscape of real-world OUD treatment, enabling critical research...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to assess the causal impact and equity effects of the New York State Medicaid Value-Based Payment (VBP) policy on outcomes related to opioid use disorder (OUD), including service use, quality, overdose, and healthcare costs. The $1,994,766 award will fund a 1-year research project to be carried out by the Cambridge Public Health Commission, doing...
This federal Project Grant award of $2,726,432.00, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a prospective cohort study examining the co-use of cannabis and prescription opioids among emerging adults (ages 18-25) in medical settings. The study aims to identify malleable risk and protective factors that influence the trajectory of opioid and cannabis co-use, particularly in the context of pain experiences....
This Project Grant award, titled "TOGETHER AGAINST OVERDOSE: COMMUNITY DEVELOPED TECHNOLOGY TO ENCOURAGE DRUG CHECKING, DISTRIBUTION OF HARM REDUCTION SUPPLIES, AND LINKAGE TO SERVICES," is funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The primary objective is to develop and evaluate technology-based interventions that increase behaviors to protect against overdose, such as drug checking, and facilitate linkage...
This $680,046 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a study to examine social functioning among individuals with opioid use disorder (OUD) during treatment. The study, titled "Real-World Assessment of Social Functioning During OUD Treatment: Integrating Reports from Patients and Their Concerned Significant Others," aims to determine how patient-reported and concerned...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $326,410 to Berkshire Biomedical Corporation to conduct a two-phased clinical study on the Computerized Oral Prescription Administration System (COPA). The COPA is a hand-held, automated, personalized oral liquid dispensing system designed to securely deliver controlled substances, including methadone, to patients with opioid use disorder...
The National Institute on Drug Abuse (NIDA) awarded a $594,122 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to Boulder Care, Inc. on September 15, 2024. The funding will support the development and testing of workflows to provide telehealth-based treatment for opioid use disorder (OUD) in high-risk settings such as jails, prisons, emergency departments, and rural tribal areas. In Phase I, Boulder Care will work with 5 partner organizations to develop and refine the...